Overview of the Cross-National Collaborative Panic Study: I. Efficacy in Short-term Treatment

Archives of General Psychiatry

Volumn 45, Issue 5, 1988, Pages 407-412

  Klerman, Gerald L ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; IMIPRAMINE;

ADULT; AGORAPHOBIA; CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PANIC; PSYCHOLOGICAL ASPECT;

AGORAPHOBIA; ALPRAZOLAM; ANXIETY DISORDERS; CLINICAL TRIALS; COMPARATIVE STUDY; FEAR; GOALS; HUMAN; IMIPRAMINE; PANIC; PLACEBOS; QUALITY CONTROL;

EID: 0023951767     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1988.01800290021003     Document Type: Article

References (31)

1. Ballenger JC, Burrows GD, DuPont RL Jr, Lesser IM, Noyes R Jr, Pecknold JC, Rifkin A, Swinson RP: Alprazolam in panic disorder and agoraphobia: Reults from a multicenter trial: I. Efficacy in short-term treatment. Arch Gen Psychiatry 1988;45:413-422.
2. Noyes R Jr, DuPont RL Jr, Pecknold JC, Rifkin A, Rubin RT, Swinson RP, Ballenger JC, Burrows GD: Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial: II. Patient acceptance, side effects, and safety. Arch Gen Psychiatry 1988;45:423-428.
3. Pecknold JC, Swinson RP, Kuch K, Lewis CP: Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial: III. Discontinuation effects. Arch Gen Psychiatry 1988;45:429-436.
4. Klerman GL, Coleman JH, Purpura RP: The design and conduct of the Upjohn Cross-National Panic Study. Psychopharmacol Bull 1986;22:59-75.
5. Roth M: The phobic anxiety: Depersonalization syndrome and some general aetiological problems in psychiatry. J Neuropsychiatry 1960;1:293-306.
6. Klein DF: Anxiety reconceptualized, in Klein DF, Rabkin JG (eds): Anxiety: New Research and Changing Concepts. New York, Raven Press, 1981, pp 235-263.
7. Tyer P: Classification of anxiety disorders. J Anxiety Dis 1986;11:99-104.
8. Marks I: Agoraphobia, panic disorder and related conditions in the DSM-III-R and ICD-10. J Psychopharmacol 1987;1:6-12.
9. Liebowitz MR, Fyer AJ, Gorman JM, Campeas R, Levin A, Davies SR, Goetz D, Klein DF: Alprazolam in the treatment of panic disorders. J Clin Psychopharmacol 1986;6:13-20.
10. McNair DM, Kahn RJ: Imipramine compared with a benzodiazepine for agoraphobia, in Klein DF, Rabkin JG (eds): Anxiety: New Research and Changing Concepts. New York, Raven Press, 1981, pp 69-80.
11. Maier W, Phillip M, Buller R: The value of structured clinical interviews. Arch Gen Psychiatry, in press.
12. Klein DF: Delineation of two drug-responsive anxiety syndromes. Psychopharmacology 1964;5:397-408.
13. Sheehan DV: Current concepts in psychiatry: Panic attacks and phobias. N Engl J Med 1982;307:156-158.
14. Sheehan DV, Davidson J, Manschreck T, Van Wyck Fleet J: Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias. J Clin Psychopharmacol 1983;3:28-31.
15. Rosenbaum J (ed): New uses for clonazepam in psychiatry. J Clin Psychiatry 1987;48:10(suppl):3.
16. Sheehan DV, Ballenger J, Jacobson G: Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. Arch Gen Psychiatry 1980;37:51-59.
17. Sheehan DV, Ballenger J, Jacobson G: Relative efficacy of monoamine oxidase inhibitors and tricyclic antidepressants in the treatment of endogenous anxiety, in Klein DF, Rabkin JG (eds): Anxiety: New Research and Changing Concepts. New York, Raven Press, 1981, pp 47-67.
18. Breier A, Charney DS, Heninger GR: The diagnostic validity of anxiety disorders and their relationship to depressive Illness. Am J Psychiatry 1985;142:787-797.
19. Marks IM: Fears, Phobias, and Rituals. New York, Oxford University Press Inc, 1987.
20. Marks IM, Gray S, Cohen D, Hill R, Mawson D, Ramm E, Stern RS: Imipramine and brief therapist-aided exposure in agoraphobics having selfexposure homework. Arch Gen Psychiatry 1983;40:153-162.
21. Lesser IM, Rubin RT, Pecknold JC, Rifkin A, Swinson RP, Lydiard RB, Burrows GD, Noyes R Jr, Dupont RL Jr: Secondary depression in panic disorder and agoraphobia: Frequency, severity, and response to treatment. Arch Gen Psychiatry 1988;45:437-443.
22. Fabre LF, McLendon DM: A double-blind study comparing the efficacy and safety of alprazolam with imipramine and placebo in primary depression. Curr Ther Res 1980;27:474-482.
23. Feighner JP, Aden GC, Fabre LF, Rickels K, Smith WT: Comparison of alprazolam, imipramine, and placebo in the treatment of depression. JAMA 1983;249:3057-3064.
24. Rickels K, Feighner JP, Smith WT: Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression. Arch Gen Psychiatry 1985;42:134-141.
25. Maier W, Buller R, Phillip M, Heuser I: The Hamilton Anxiety Scale: Reliability, validity, sensitivity to change in anxiety and depressive disorders. J Psychiatr Res, in press.
26. Eriksson E, Carlson M, Nison C, Soderpalm B: Does alprazolam, in contrast to diazepam, activate alpha adrenoceptors involved in the regulation of rat growth hormone secretion? Life Sci 1986;38:1491-1498.
27. Kornecki E, Ehrlich YH, Lenox RH: Platelet-activating factorinduced aggregation of human platelets specifically inhibited by triazolobenzodiazepines. Science 1984;226:1454-1456.
28. Mooney JJ, Schatzberg AF, Cole JO, Kazuka PP, Schildkraut JJ: Enhanced signal transduction by adenylate antidepressant responses to alprazolam: Preliminary data. J Psychiatr Res 1985;19:65-71.
29. Sethy VH, Hodges DH: Role of beta-adrenergic receptors in the antidepressant activity of alprazolam. Res Commun Chem Pathol Pharmacol 1982;36:329-332.
30. Clark DM, Salkovskis PM, Chalkley AJ: Respiratory control as a treatment for panic attacks. J Behav Ther Exp Psychiatry 1985;16:23-30.
31. Salkovskis PM, Jones DRO, Clark DM: Respiratory control in the treatment of panic attacks: Replication. Br J Psychiatry 1986;148:526-532.